Becton Dickinson and Stock Price, News & Analysis (NYSE:BDX)

$253.55
-2.83 (-1.10 %)
(As of 09/22/2019 06:07 AM ET)
Today's Range
$253.28
Now: $253.55
$256.6250
50-Day Range
$237.94
MA: $252.96
$263.31
52-Week Range
$208.62
Now: $253.55
$265.87
Volume1.45 million shs
Average Volume887,302 shs
Market Capitalization$68.45 billion
P/E Ratio22.69
Dividend Yield1.20%
Beta1.13
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.98 billion
Cash Flow$18.0334 per share
Book Value$78.25 per share

Profitability

Net Income$311 million

Miscellaneous

Employees76,032
Market Cap$68.45 billion
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.


Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and announced a quarterly dividend on Monday, July 22nd. Stockholders of record on Monday, September 9th will be paid a dividend of $0.77 per share on Monday, September 30th. This represents a $3.08 annualized dividend and a dividend yield of 1.21%. The ex-dividend date is Friday, September 6th. View Becton Dickinson and's Dividend History.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) issued its quarterly earnings data on Tuesday, August, 6th. The medical instruments supplier reported $3.08 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $3.05 by $0.03. The medical instruments supplier had revenue of $4.35 billion for the quarter, compared to analysts' expectations of $4.37 billion. Becton Dickinson and had a net margin of 5.02% and a return on equity of 14.78%. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $2.91 EPS. View Becton Dickinson and's Earnings History.

When is Becton Dickinson and's next earnings date?

Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Becton Dickinson and.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and updated its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of $11.65-11.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.68. The company issued revenue guidance of $17.26164-17.42147 billion, compared to the consensus revenue estimate of $17.28 billion.

What price target have analysts set for BDX?

10 analysts have issued 12-month target prices for Becton Dickinson and's shares. Their predictions range from $250.00 to $290.00. On average, they expect Becton Dickinson and's share price to reach $268.90 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for Becton Dickinson and.

What is the consensus analysts' recommendation for Becton Dickinson and?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton Dickinson and in the last year. There are currently 3 hold ratings, 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Becton Dickinson and.

Has Becton Dickinson and been receiving favorable news coverage?

Media coverage about BDX stock has been trending somewhat negative on Sunday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Becton Dickinson and earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Becton Dickinson and.

Who are some of Becton Dickinson and's key competitors?

What other stocks do shareholders of Becton Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton Dickinson and investors own include Johnson & Johnson (JNJ), Cardinal Health (CAH), Home Depot (HD), Walt Disney (DIS), AT&T (T), Chevron (CVX), Exxon Mobil (XOM), NVIDIA (NVDA), Visa (V) and Procter & Gamble (PG).

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the folowing people:
  • Mr. Vincent A. Forlenza, Chairman & CEO (Age 66)
  • Mr. Thomas E. Polen Jr., Pres & COO (Age 46)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 62)
  • Mr. Samrat S. Khichi, Exec. VP & Gen. Counsel (Age 52)
  • Mr. Patrick K. Kaltenbach, Exec. VP & Pres of the Life Sciences Segment (Age 56)

Who are Becton Dickinson and's major shareholders?

Becton Dickinson and's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (12.69%), Vanguard Group Inc. (8.53%), BlackRock Inc. (7.01%), BlackRock Inc. (7.01%), Morgan Stanley (1.81%) and JPMorgan Chase & Co. (1.64%). Company insiders that own Becton Dickinson and stock include Alexandre Conroy, Betty D Larson, Catherine M Burzik, Charles R Bodner, Claire Fraser, David F Melcher, James C Lim, James W Borzi, John E Gallagher, Nabil Shabshab, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and.

Which institutional investors are selling Becton Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including Putnam Investments LLC, Mackenzie Financial Corp, Fiera Capital Corp, Marshall Wace North America L.P., Quest Capital Management Inc. ADV, Prudential Financial Inc., Invesco Ltd. and BlackRock Inc.. Company insiders that have sold Becton Dickinson and company stock in the last year include Alexandre Conroy, Betty D Larson, Charles R Bodner, Claire Fraser, James C Lim, James W Borzi, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Insider Buying and Selling for Becton Dickinson and.

Which institutional investors are buying Becton Dickinson and stock?

BDX stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Nuveen Asset Management LLC, Thoroughbred Financial Services LLC, Vanguard Group Inc., Stonehage Fleming Financial Services Holdings Ltd, Intermede Investment Partners Ltd, Senator Investment Group LP and Cantillon Capital Management LLC. Company insiders that have bought Becton Dickinson and stock in the last two years include Catherine M Burzik and David F Melcher. View Insider Buying and Selling for Becton Dickinson and.

How do I buy shares of Becton Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $253.55.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $68.45 billion and generates $15.98 billion in revenue each year. The medical instruments supplier earns $311 million in net income (profit) each year or $11.01 on an earnings per share basis. Becton Dickinson and employs 76,032 workers across the globe.View Additional Information About Becton Dickinson and.

What is Becton Dickinson and's official website?

The official website for Becton Dickinson and is http://www.bd.com/.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


MarketBeat Community Rating for Becton Dickinson and (NYSE BDX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  473 (Vote Outperform)
Underperform Votes:  555 (Vote Underperform)
Total Votes:  1,028
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe BDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel